Statistical evaluation of cerebral autoregulation indices at different time points during the experiment: baseline, last LBNP/LBPP level (LBNP: first 10 seconds), presyncope (5 sec... by Marcus Thudium (6441863)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Results for the gap decrease. by Jan Wieding (328185)

The standard deviation of the mean total population abundance was calculated at each time step. by Cyrine Chenaoui (22177098)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Insulin decreases the interspike interval (ISI) and cluster pause duration of mitral cell action potential activity. by Debra Ann Fadool (332114)

Activation of mitoK_ATP channels decreased the latency time of the transjunctional currents in slice. by Jiangping Wang (281901)

“…<p>(<b>A</b>) Currents in S_cell induced by a pair of ±160 mV voltage steps and the transjunctional currents received by the R_cell. …”

Cobalt decreases the expression of AQP5 expression in MLE-12 cells. by Jitesh D. Kawedia (384551)

Decreased autoantibody production in IRF5-deficient MRL/lpr mice. by Kei Yasuda (606333)

Impact of 5HT stimulation on the plasma membrane density of truncated and mutant transporters. by Billow A. Ahmed (266461)

“…<p>CHO cells expressing truncated or mutant forms of transporter were either directly <i>(A and B)</i> or after stimulated with 100 μM 5HT <i>(C and D)</i> subjected to the cell surface biotinylation assays. …”

Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

“…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”

Data Sheet 1_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.pdf by Evan Fuini (21224939)

Table 4_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Data Sheet 2_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.docx by Evan Fuini (21224939)

Table 1_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.docx by Evan Fuini (21224939)

Table 5_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Table 2_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Table 3_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Flibanserin’s neuroprotective effects are 5-HT_1A receptor-mediated. by Aaron S. Coyner (2889722)

“…A 6 mg/kg dose of flibanserin in 5-HT_1A knockout mice (5-HT1A KO + 6 mg/kg Flibanserin, <i>red</i>) resulted in average receptor plus thickness that was not significantly different from vehicle-injected and naïve mice. …”

Diclofenac decreases angiogenesis. by Nina Mayorek (241888)